Fang Ni
Director of Finance/CFO presso BLACK DIAMOND THERAPEUTICS, INC.
Patrimonio netto: 635 722 $ in data 31/03/2024
Profilo
Fang Ni is currently the Chief Financial & Business Officer at Black Diamond Therapeutics, Inc. Prior to this role, Dr. Ni worked as the Director-Global Business Development & Licensing at F.
Hoffmann-La Roche Ltd.
from 2013 to 2017.
From 2017 to 2020, Dr. Ni served as a Principal at Versant Ventures (Switzerland) GmbH.
Dr. Ni also held the position of Chief Business Officer at Monte Rosa Therapeutics AG and Bright Peak Therapeutics AG.
Dr. Ni obtained a doctorate degree from Purdue University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 14/02/2024 | 125 389 ( 0.24% ) | 635 722 $ | 31/03/2024 |
Posizioni attive di Fang Ni
| Società | Posizione | Inizio |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Director of Finance/CFO | 19/11/2021 |
Precedenti posizioni note di Fang Ni
| Società | Posizione | Fine |
|---|---|---|
| Versant Ventures (Switzerland) GmbH | Private Equity Analyst | 01/08/2020 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/11/2017 |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Formazione di Fang Ni
| Purdue University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
| Versant Ventures (Switzerland) GmbH | Finance |
Monte Rosa Therapeutics AG
Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Health Technology |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Fang Ni
